Skip to content

Clinical Study of Recombinant Bone Morphogenetic Protein - 2 Composite Calcium Phosphate Cement in Alveolar Bone Defect

Clinical Study of Recombinant Bone Morphogenetic Protein - 2 Composite Calcium Phosphate Cement in Alveolar Bone Defect

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036096
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Defect

Interventions

BC:rhBMP2
Control:Bio-Oss

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 25-60 years, male or femal; 2. Presence of a hopeless molar with severe bone destruction requiring extraction due to advanced periodontal disease and At least two socket walls with alveolar bone beyond the apex of the extraction socket 3mm and one adjacent tooth at the ajacent region; 3. need implant treatment after the tooth extraction; 4. Able to comply with study-related procedures and recall visits; 5. Physical health or well-controlled systemic diseases; 6. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The surgical site has received bone graft before; 2. The patient has a serious systemic disease such as heart disease or coagulation dysfunction in the past six months; 3. Mental abnormality and inability to act autonomously; 4. Smoking more than 10 per day; 5. Poor oral hygiene; 6. Active infectious disease, metabolic bone disease active period; 7. Pregnant or breastfeeding; 8. Teeth with extreme bone loss or gingival recession; 9. Absence of both adjacent teeth; 10. Teeth with ongoing acute pathology: abscess, suppuration, and severe swelling; 11. Tooth extracted due to dental caries, root canal treatment failure or trauma.

Design outcomes

Primary

MeasureTime frame
CBCT;

Countries

China

Contacts

Public ContactXinquan Jiang

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

xinquanj@aliyun.com+86 18019790557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026